Wednesday, February 4, 2009
Ever heard of an accountant? Death Knell to Obamacare?
Posted by
Steve Murphy MD
at
4:02 AM
2
comments
Labels: barack obama, coriell personalized medicine collaborative, daschle, Helix Health of Connecticut, navigenics, obamacare
Tuesday, February 3, 2009
Fast Facts About CPMC
Launched by Coriell Institute for Medical Research in December 2007, the CPMC is an
evidence-based research study designed to determine the benefit of using personal
genome information in clinical decision-making.
Goals
The CPMC is a forward-looking, collaborative effort involving physicians, scientists,
ethicists, genetic counselors, information technology experts and volunteer study
participants. The goal is to better understand the impact of genome-informed medicine and
to guide its ethical, legal and responsible implementation.
The CPMC also aims to understand why people often respond differently to treatments, and
to discover presently unknown genes that elevate a person’s risk of cancer and other
complex diseases.
Key Points of Differentiation
The CPMC is unlike any other organization that supplies personal genetic information to
individuals.
▪ First, the CPMC is a research study that has been approved by an Institutional Review
Board, whose mission is to review research studies involving human subjects to ensure that
the rights of research participants are protected.
▪ Second, the CPMC is a research study that provides participants with information about
themselves. Many research studies ask for subjects to participate for the good of science
while supplying little or no information back to participants.
▪ Third, the CPMC is not returning all personal genetic information back to participants but
only variants that an external advisory board (the Informed Cohort Oversight Board) has
deemed potentially medically actionable. The actions of this board are completely transparent.
▪ Fourth, the CPMC is requiring participants to complete web-based surveys. After
establishing an account on the web portal, participants will be asked to complete a series of
questionnaires regarding their medical history, family history and lifestyle. Some of this
information will be used to customize participant genetic variant reports, by adding
information provided in the surveys (age, smoking status etc) that affects risk for a health
condition.
▪ Fifth, participants are given control of their personal genetic variant information and can
opt to allow access to their genetic result data to physicians, CPMC genetic counselors or
others.
▪ Sixth, participants in the CPMC study can opt to release their de-identified genetic and
medical history information to the biomedical research community. It is completely voluntary.
▪ Seventh, the CPMC plans to enroll individuals with cancer through their healthcare
provider as well as participants from the general public through open informed consent
sessions.
Posted by
Steve Murphy MD
at
9:09 AM
7
comments
Labels: 23 and me, barack obama, coriell personalized medicine collaborative, Helix Health of Connecticut, navigenics
Monday, February 2, 2009
Coriell Goes Live!!!
Today the Coriell Personalized Medicine Collaborative website goes live. After many months of really hard work they are ready to show everyone what a Personalized Medicine Collaborative Study looks like. I maintain, without the information to be generated by Coriell, we have absolutely no clue what the heck these DTC SNP scans are clinically worth.
The Coriell Institute has been granted a Certificate of Confidentiality under a federal law (Section 301(d) of the Public Health Service Act). This means that records from the CPMC study may not be disclosed, under federal, state or local court order, without your written approval. Data that are protected by a Certificate of Confidentiality may be disclosed to the Department of Health and Human Services if required for audits of research records.
Posted by
Steve Murphy MD
at
3:41 AM
10
comments
Labels: coriell, coriell personalized medicine collaborative, cpmc, Helix Health of Connecticut, virtua healthcare
Saturday, January 31, 2009
Razzle Dazzle 'Em Part Deux
I was reading Daniel's Blog and this person's comments caught my eye...
"The marketplace for genetic testing is basically an uneducated one (with the exception of people who are really excited about it)."
I think she is right. To do the education to get someone to use this test will ultimately make them not use this test...because once you can understand the implications, you could understand that these tests are of limited value.......unlike Pgx testing...
Caveat: I like the people at Navigenics. I think they have great scientists. BUT, I am extremely skeptical of any physician who is working for this company to promote tests which are not clinically validated.....
To continue...
She then goes further....
"Add to that, Navigenics also wanted to offer disease related testing (I'm leaving the question of clinical utility aside here since the only people who have thought usefully about that are the deCode folks, and apparently not the Navis, 23s, etc.)
So, they realized that to keep an uneducated customer happy while contemplating medically related information, they were going to need to make it easy for that person to pick up the phone and talk to an "expert". "
Spot on......too bad the expert is a genetic counselor who has no medical training in explaining heart disease, multiple sclerosis or anything other than cancer, prenatal issues "Family planning" or monogenic disease.......the model that they were trained for.... What would you do with a woman who had a systolic BP of 136 Elissa? Could you suggest anything?...Wouldn't it be smarter if they actually talked to doctors who understood what these tests meant and who had cared for people with these diseases???? And even with clinical utility aside, deCode has failed to prove clinical utility of their tests.....
The commenter is wrong again down here........but in an extremely correct way......
"That's what they got right. Personalized genetic testing is not about the test, which is a commodity, or the "report" which is useless to most doctors, mothers, etc., but the information, which is currently best conveyed through a person who can answer questions. And people cost a lot of money, thus the ridiculously high price."
Exactly, the cobbler issue.....but I doubt,
1. That the genetic counselor is getting paid 2000 per consult. If you subtract the costs of the test from the charge, that is what you get.....
2. That the counselor is even close to a replacement for a physician....not even close when it comes to adult disease management.......
But she is absolutely correct. It costs a lot to speak with someone, which is why VC always hated Helix Health of Connecticut's model of healthcare...Too bad for them. Patients are using it.....
Just then, she had an absolutely correct point, which is exactly what Navigenics hit square on the head......they were so right in this one way!
"Personalized genetic testing is about people getting attention they feel they need or want enough to pay for it, because they can't get it from their PCP anymore on their insurance co.'s dime."
This my dear is called concierge medicine and it is why Navigenics has partnered with the Internists and Family Practitioners of MDVIP........If not to bolster the impression that their unvalidated test IS Clinically valid (Very sneaky, guys)
But I wonder how MDVIP is doing, using these tests and charging patients for it.......since after all
1) In Navigenics Terms of Service, you can't use it for healthcare
2) Most Internists and FPs need about 6 months of genetics training to understand genetics
3) Most of the info in that report gives us no advantage clinically.
And then she nails the point home:
"Any company that can capitalize on that (regardless of whether the test is clinically useful or just hand waving) will have a market."
Have any of you watched Chicago? This is exactly what I call Razzle Dazzle 'Em.......baffle the people with bull$h!+ and they will think you are worth something.......Hell, it is how these companies were sold the Venture Capital in the first place.....
"Navigenics hit much closer to this mark than the other big 3."
I agree, hand waving and bull$h!+, precisely what this company is offering........otherwise they would have hired physicians to go over the reports with patients rather than genetic counselors....
That to me is the proof of what they feel is important........
For the millions they spent in NYC (there is no shop in SoHo) they could have had Geneticists and Internists who actually get this stuff. They could have them hired at 130k per year.....what's that? 10 Doctors who know what they're doing for a year or 20 counselors who won't tell the patients that they wasted their time on clinically useless testing?
Oh wait.......last time I checked, Navi didn't even have more than 3 counselors doing the clinical work. So if Navi is so into the clinical side, why didn't they hire enough people for the job......Nor did decode or 23andMe..
Oh wait, maybe they have? All 3 have an extensive marketing team and web development team.............. deCode , Navigenics , 23andMe
All are looking for more......
As for the commenter? She works for a company who provides services around bead technology.......
The Sherpa Says: All 3 of these companies are struggling to find themselves......as I have said before, no one knows the true value of these tests yet. Which is why they should be studied......in a rigorous, IRB approved fashion, not anecdotally........Dietrich, you should have had your team listen to me about a year ago when we spoke......I could have gotten you there quicker.........One test is called a one hit wonder....a platform.....is worth so much more.
Posted by
Steve Murphy MD
at
4:19 AM
2
comments
Labels: 23 and me, deCODEme, DNA direct, Helix Health of Connecticut, navigenics
Thursday, January 29, 2009
Navigenics does market research, finally.
Example Navi: Who didn't know this was coming? I sure as hell did when I sat with their marketing team and they asked why I wasn't ordering their test....
I told them that I had patients paying less for our services for the year than for their test....Prior to that I saw their marketing survey on Gerson Lehman Group....thank for the quick cash Navi! There was the first time I saw the"scaled down test for 500 dollars"
IMHO, it was a non starter....Now for 499 and a year's access to your data......it is STILL a nonstarter.
In a short amount of time the price of these tests will be Zero Dollars.....
Those who survive this little pricewar will realize that the distribution platform matters way more than any individual test....
Too bad the 30 or so VC firms we spoke with didn't want to believe this.....now, it looks as if Amway or MarketAmerica may be a better investment after all....
But in all seriousness, these companies have a choice over the next six months...
1. Go medical with PgX and get the hell regulated out of you (No, Schmidt cannot protect 23andMe)
2. Go Novelty, with ancestry, innate traits, etc.
3. dissolve the testing and turn into a platform...
The Sherpa Says: All that glitters in this DTC space has been and will continue to be fools gold for at least the forseeable future.....No matter how many cocktail parties you throw SoHo....
Posted by
Steve Murphy MD
at
4:03 AM
7
comments
Labels: 23andme, barack obama, deCODEme, Helix Health of Connecticut, navigenics
Wednesday, January 28, 2009
Plavix, Plavix, Plavix
Posted by
Steve Murphy MD
at
8:29 AM
1 comments
Labels: ACP, barack obama, bms, Helix Health of Connecticut, pharmacogenomics, plavix, wyeth
Monday, January 26, 2009
Harsh on All Fronts!
Posted by
Steve Murphy MD
at
3:45 AM
3
comments
Labels: 23 and me, abim, ACMG, ACP, CGC, coriell personalized medicine collaborative, helicos, Helix Health of Connecticut, navigenics, NSGC



